Zhao S, Zhou H, Yang N, Wang Z, et al. Safety, efficacy and biomarker analysis of deulorlatinib (TGRX-326) in ALK-positive non-small-cell lung cancer: a multicentre, open-label, phase 1/1b trial. J Thorac Oncol 2024 Nov 15:S1556-0864(24)02445.
PMID: 39551469